Vaccination and immunization against travel-related diseases in immunocompromised hosts

References

• Boggild AK, Sano M, Humar A, Salit I, Gilman M, Kain KC. Travel patterns and risk behavior in solid organ transplant recipients. J. Travel Med.11(1), 37–43 (2004).
   PubMed Web of Science ®Google Scholar
• No authors listed. Advising travelers with specific needs: the immunocompromised traveler. In: Health Information for International Travel 2007–2008: the Yellow Book. Centers for Disease Control, Department of Health and Human Services, Atlanta, GA, USA (2008).
   Google Scholar
• Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveller. An Advisory Committee Statement (ACS). Can. Commun. Dis. Rep.33(ACS-4), 1–24 (2007).
   PubMedGoogle Scholar
• Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin. Arthritis Rheum.33(4), 283–288 (2004).
   PubMed Web of Science ®Google Scholar
• Fishman JA. Infection in solid-organ transplant recipients. N. Engl. J. Med.357(25), 2601–2614 (2007).
   PubMed Web of Science ®Google Scholar
• van der Velden AM, Claessen AM, van Velzen-Blad H et al. Vaccination responses and lymphocyte subsets after autologous stem cell transplantation. Vaccine25(51), 8512–8517 (2007).
   PubMed Web of Science ®Google Scholar
• Magnani G, Falchetti E, Pollini G et al. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study. J. Heart Lung Transplant.24(5), 588–592 (2005).
   PubMed Web of Science ®Google Scholar
• Nevens F, Zuckerman JN, Burroughs AK et al. Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients. Liver Transpl.12(10), 1489–1495 (2006).
   PubMed Web of Science ®Google Scholar
• Rosenau J, Hooman N, Rifai K et al. Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response. Transpl. Int.19(10), 828–833 (2006).
   PubMed Web of Science ®Google Scholar
• Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA298(18), 2155–2163 (2007).
   PubMed Web of Science ®Google Scholar
• Henning KJ, White MH, Sepkowitz KA, Armstrong D. A national survey of immunization practices following allogeneic bone marrow transplantation. JAMA277(14), 1148–1151 (1997).
   PubMed Web of Science ®Google Scholar
• Avery RK, Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am. J. Transplant.8(1), 9–14 (2008).
   PubMed Web of Science ®Google Scholar
• Guidelines for vaccination of solid organ transplant candidates and recipients. Am. J. Transplant.4(Suppl. 10), 160–163 (2004).
   Google Scholar
• Ballout A, Goffin E, Yombi JC, Vandercam B. Vaccinations for adult solid organ transplant recipient: current recommendations. Transplant. Proc.37(6), 2826–2827 (2005).
   PubMed Web of Science ®Google Scholar
• Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin. Microbiol. Rev.16(3), 357–364 (2003).
   PubMed Web of Science ®Google Scholar
• Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am. J. Transplant.5(1), 8–14 (2005).
   PubMed Web of Science ®Google Scholar
• Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin. Infect. Dis.33(2), 139–144 (2001).
   PubMed Web of Science ®Google Scholar
• Ljungman P, Engelhard D, de la Camara R et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant.35(8), 737–746 (2005).
   PubMed Web of Science ®Google Scholar
• Machado CM. Reimmunization after hematopoietic stem cell transplantation. Expert Rev. Vaccines4(2), 219–228 (2005).
   PubMed Web of Science ®Google Scholar
• Leung AY, Chow HC, Kwok JS et al. Safety of vaccinating sibling donors with live-attenuated varicella zoster vaccine before hematopoietic stem cell transplantation. Bone Marrow Transplant.39(11), 661–665 (2007).
   PubMed Web of Science ®Google Scholar
• Storek J, Viganego F, Dawson MA et al. Factors affecting antibody levels after allogeneic hematopoietic cell transplantation. Blood101(8), 3319–3324 (2003).
   PubMed Web of Science ®Google Scholar
• Kumar D, Welsh B, Siegal D, Chen MH, Humar A. Immunogenicity of pneumococcal vaccine in renal transplant recipients – three year follow-up of a randomized trial. Am. J. Transplant.7(3), 633–638 (2007).
   PubMed Web of Science ®Google Scholar
• Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin. Infect. Dis.33(Suppl. 1), S15–S21 (2001).
   Web of Science ®Google Scholar
• Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect. Dis. Clin. North Am.15(1), 273–305, xii (2001).
   PubMed Web of Science ®Google Scholar
• Health Information for International Travel 2007–2008: the Yellow Book. Centers for Disease Control, Department of Health and Human Services, Atlanta, GA, USA (2007).
   Google Scholar
• Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J. Pediatr.123(1), 87–89 (1993).
   PubMed Web of Science ®Google Scholar
• Hayney MS, Welter DL, Reynolds AM, Francois M, Love RB. High-dose hepatitis B vaccine in patients waiting for lung transplantation. Pharmacotherapy23(5), 555–560 (2003).
   PubMed Web of Science ®Google Scholar
• Bienzle U, Gunther M, Neuhaus R et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology38(4), 811–819 (2003).
   PubMed Web of Science ®Google Scholar
• Choy BY, Peiris JS, Chan TM, Lo SK, Lui SL, Lai KN. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am. J. Transplant.2(10), 965–969 (2002).
   PubMed Web of Science ®Google Scholar
• Laurence JC. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am. J. Med.118(Suppl. 10A), S75–S83 (2005).
   PubMed Web of Science ®Google Scholar
• Jaffe D, Papadopoulos EB, Young JW et al. Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood108(7), 2470–2475 (2006).
   PubMed Web of Science ®Google Scholar
• Ljungman P, Wang FZ, Nilsson C, Solheim V, Linde A. Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study. Support Care Cancer11(11), 739–741 (2003).
   PubMed Web of Science ®Google Scholar
• Hata A, Asanuma H, Rinki M et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N. Engl. J. Med.347(1), 26–34 (2002).
   PubMed Web of Science ®Google Scholar
• Ryan ET, Kain KC. Health advice and immunizations for travelers. N. Engl. J. Med.342(23), 1716–1725 (2000).
   PubMed Web of Science ®Google Scholar
• Mutsch M, Spicher VM, Gut C, Steffen R. Hepatitis A virus infections in travelers, 1988–2004. Clin. Infect. Dis.42(4), 490–497 (2006).
   PubMed Web of Science ®Google Scholar
• Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation72(2), 272–276 (2001).
   PubMed Web of Science ®Google Scholar
• Dumot JA, Barnes DS, Younossi Z et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am. J. Gastroenterol.94(6), 1601–1604 (1999).
   PubMed Web of Science ®Google Scholar
• Stark K, Gunther M, Neuhaus R et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J. Infect. Dis.180(6), 2014–2017 (1999).
   PubMed Web of Science ®Google Scholar
• Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation71(3), 477–479 (2001).
   PubMed Web of Science ®Google Scholar
• Rendi-Wagner P, Korinek M, Winkler B, Kundi M, Kollaritsch H, Wiedermann U. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine25(5), 927–931 (2007).
   PubMed Web of Science ®Google Scholar
• Overton ET, Nurutdinova D, Sungkanuparph S, Seyfried W, Groger RK, Powderly WG. Predictors of immunity after hepatitis A vaccination in HIV-infected persons. J. Viral Hepat.14(3), 189–193 (2007).
   PubMed Web of Science ®Google Scholar
• Weissman S, Feucht C, Moore BA. Response to hepatitis A vaccine in HIV-positive patients. J. Viral Hepat.13(2), 81–86 (2006).
   PubMed Web of Science ®Google Scholar
• Rimland D, Guest JL. Response to hepatitis A vaccine in HIV patients in the HAART era. AIDS19(15), 1702–1704 (2005).
   PubMed Web of Science ®Google Scholar
• Wallace MR, Brandt CJ, Earhart KC et al. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects. Clin. Infect. Dis.39(8), 1207–1213 (2004).
   PubMed Web of Science ®Google Scholar
• Kroon FP, van Dissel JT, Ravensbergen E, Nibbering PH, van Furth R. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi). Vaccine17(23–24), 2941–2945 (1999).
   PubMed Web of Science ®Google Scholar
• Begier EM, Burwen DR, Haber P, Ball R. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Clin. Infect. Dis.38(6), 771–779 (2004).
   PubMed Web of Science ®Google Scholar
• Ljungman P, Aschan J, Gustafsson B, Lewensohn-Fuchs I, Winiarski J, Ringden O. Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients. Bone Marrow Transplant.34(12), 1067–1069 (2004).
   PubMed Web of Science ®Google Scholar
• Parkkali T, Kayhty H, Lehtonen H et al. Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients. Bone Marrow Transplant.27(1), 79–84 (2001).
   PubMed Web of Science ®Google Scholar
• Patel SR, Ortin M, Cohen BJ et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin. Infect. Dis.44(5), 625–634 (2007).
   PubMed Web of Science ®Google Scholar
• Yu JW, Borkowski A, Danzig L, Reiter S, Kavan P, Mazer BD. Immune response to conjugated meningococcal C vaccine in pediatric oncology patients. Pediatr. Blood Cancer49(7), 918–923 (2007).
   PubMed Web of Science ®Google Scholar
• Lin PL, Michaels MG, Green M et al. Safety and immunogenicity of the American Academy of Pediatrics – recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics116(1), 160–167 (2005).
   PubMed Web of Science ®Google Scholar
• Birx DL, Rhoads JL, Wright JC, Burke DS, Redfield RR. Immunologic parameters in early-stage HIV-seropositive subjects associated with vaccine responsiveness. J. Acquir. Immune Defic. Syndr.4(2), 188–196 (1991).
   PubMed Web of Science ®Google Scholar
• Cetron MS, Marfin AA, Julian KG et al. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm. Rep.51(RR-17), 1–11 (2002).
   PubMedGoogle Scholar
• Fishman JA. Smallpox and live-virus vaccination in transplant recipients. Am. J. Transplant.3(7), 786–793 (2003).
   PubMed Web of Science ®Google Scholar
• Ljungman P. Vaccination of transplant recipients. In: Transplant Infections. Bowden RA, Ljungman P, Paya CV (Eds). Lippincott Williams & Wilkins, PA, USA 611–624 (2003).
   Google Scholar
• Mileno M. Preparation of immunocompromised travelers. In: Travel Medicine (1st edition). Keystone JS, Freedman DP, Nothdurft HD, Connor BA (Eds). Mosby, Edinburgh, UK 249–255 (2004).
   Google Scholar
• Gowda R, Cartwright K, Bremner JA, Green ST. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur. J. Haematol.72(4), 299–301 (2004).
   PubMed Web of Science ®Google Scholar
• Receveur MC, Thiebaut R, Vedy S, Malvy D, Mercie P, Bras ML. Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases. Clin. Infect. Dis.31(3), E7–E8 (2000).
   PubMed Web of Science ®Google Scholar
• Tattevin P, Depatureaux AG, Chapplain JM et al. Yellow fever vaccine is safe and effective in HIV-infected patients. AIDS18(5), 825–827 (2004).
   PubMed Web of Science ®Google Scholar
• Ho YL, Enohata T, Lopes MH, De Sousa Dos Santos S. Vaccination in Brazilian HIV-infected adults: a cross-sectional study. AIDS Patient Care STDS22(1), 65–70 (2007).
   Web of Science ®Google Scholar
• Kengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J. Med. Assoc. Thai.85(1), 131–134 (2002).
   PubMedGoogle Scholar
• Gibbons RV, Rupprecht CE. Postexposure rabies prophylaxis in immunosuppressed patients. JAMA285(12), 1574–1575 (2001).
   PubMedGoogle Scholar
• Tantawichien T, Jaijaroensup W, Khawplod P, Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Clin. Infect. Dis.33(10), E122–E124 (2001).
   PubMed Web of Science ®Google Scholar
• Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.42(RR-1), 1–15 (1993).
   PubMedGoogle Scholar
• Rojanasuphot S, Shaffer N, Chotpitayasunondh T et al. Response to JE vaccine among HIV-infected children, Bangkok, Thailand. Southeast Asian J. Trop. Med. Public Health29(3), 443–450 (1998).
   PubMedGoogle Scholar
• Puthanakit T, Aurpibul L, Yoksan S, Sirisanthana T, Sirisanthana V. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine25(49), 8257–8261 (2007).
   PubMed Web of Science ®Google Scholar
• Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.56(RR-4), 1–40 (2007).
   PubMedGoogle Scholar
• Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin. Infect. Dis.35(9), 1088–1095 (2002).
   PubMed Web of Science ®Google Scholar
• Hackett PH, Roach RC. High-altitude illness. N. Engl. J. Med.345(2), 107–114 (2001).
   PubMed Web of Science ®Google Scholar